| dc.contributor.author | Mahilet, Balew | |
| dc.date.accessioned | 2022-03-24T11:44:23Z | |
| dc.date.available | 2022-03-24T11:44:23Z | |
| dc.date.issued | 2022-03-24 | |
| dc.identifier.uri | http://ir.bdu.edu.et/handle/123456789/13277 | |
| dc.description.abstract | Introduction: Chronic hepatitis C virus (HCV) has become the global “epidemic” with an estimated of 2.5% (177.5 million) people currently infected worldwide. In Ethiopia the pooled prevalence estimated is 2%. HCV infection transmission is associated with Percutaneous (dirty needles, blood transfusions, & hemodialysis, Intranasal cocaine Non-commercial tattooing & body piercing, via contaminated multi-use vials & inadequately sterilized multi-use instruments & syringes.), and Non-percutaneous (sexual). At the same time diabetes is also rapidly emerging as a global health care problem that threatens to reach pandemic levels by 2030. | en_US |
| dc.language.iso | en | en_US |
| dc.subject | The study confirmed a lower rate of HCV in Type II DM patients in TGSH than previous study in Ethiopia. Which show that hcv infection may be a possible risk factor for type 2DM,but not statistically significant .This finding didn’t not allow to recommend regular screening for HCV infection in type 2 diabetics | en_US |
| dc.title | SERO PREVALENCE OF HEPATITIS C VIRUS INFECTION AND ASSOCIATED RISK FACTORS IN TYPE II DIABETIC PATIENTS IN TIBEBE GIYON SPECIALIZED HOSPITAL(TGSH), BAHIRDAR, ETHMAHLEIOPIA,2021 | en_US |
| dc.type | Thesis | en_US |